New Weight-Loss drug candidate enters early human testing
NCT ID NCT06945419
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 26 times
Summary
This early-stage study tests a new medicine called LY4086940 in healthy people and those who are overweight or have obesity, with or without type 2 diabetes. The main goal is to check the drug's safety and how the body processes it. About 216 participants will take part in different parts of the study lasting 7 to 15 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CenExel iResearch, LLC
NOT_YET_RECRUITINGDecatur, Georgia, 30030, United States
Contact Phone: •••-•••-••••
Contact
-
Clinical Pharmacology of Miami
RECRUITINGMiami, Florida, 33172, United States
Contact Phone: •••-•••-••••
Contact
-
Endeavor Clinical Trials
RECRUITINGSan Antonio, Texas, 78240, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit
ACTIVE_NOT_RECRUITINGDaytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit
COMPLETEDDallas, Texas, 75247, United States
-
Lilly Centre for Clinical Pharmacology
COMPLETEDSingapore, 138623, Singapore
Conditions
Explore the condition pages connected to this study.